Compare VVOS & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | AQMS |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7M | 20.9M |
| IPO Year | 2020 | 2015 |
| Metric | VVOS | AQMS |
|---|---|---|
| Price | $1.82 | $5.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $6.25 | ★ $12.00 |
| AVG Volume (30 Days) | 149.2K | ★ 737.3K |
| Earning Date | 11-19-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,317,000.00 | N/A |
| Revenue This Year | $28.86 | N/A |
| Revenue Next Year | $48.70 | $550.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.76 | N/A |
| 52 Week Low | $1.67 | $3.37 |
| 52 Week High | $7.95 | $39.40 |
| Indicator | VVOS | AQMS |
|---|---|---|
| Relative Strength Index (RSI) | 37.92 | 46.19 |
| Support Level | $1.67 | $5.06 |
| Resistance Level | $1.83 | $7.65 |
| Average True Range (ATR) | 0.16 | 0.53 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 16.39 | 21.90 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.